Federal health officials convened a closed-door “clinical AI demo day” on July 8, 2026 at the Food and Drug Administration’s White Oak headquarters. According to an agenda reviewed by STAT, the event brought together officials from the FDA and the Centers for Medicare and Medicaid Services (CMS) with representatives of multiple companies developing clinical artificial intelligence. The meeting was not publicly announced, and the source describes it as a private briefing designed to give regulators firsthand experience with existing AI-driven clinical tools.
The agenda reviewed by STAT listed ten companies as participants: Anthropic, Counsel Health, Curai, K Health, Microsoft AI, Amazon One Medical, Doctronic, Ellipsis Health, Hippocratic AI, and Welldoc. The source presents this list as the set of organizations that met with FDA and CMS officials during the July 8 event.
STAT spoke with four companies that attended the event — Counsel Health, K Health, Hippocratic AI, and Ellipsis Health — and the article reports that those companies summarized their comments to regulators. The source does not reproduce detailed transcripts or full statements from those firms; it reports only that STAT obtained summaries conveyed by the companies.
Per the agenda and STAT reporting, the meeting’s intent was to allow federal officials to see and experience AI doctor technology as it exists today. For regulators, the demos offered direct exposure to the capabilities and user interactions of clinical AI systems. For participating companies, the gathering provided an opportunity to present their technologies to regulators engaged in shaping oversight and payment policy.
The attendees ranged from major technology firms to venture-backed startups. STAT notes that some attending startups have financial backing from prominent venture firms such as Andreessen Horowitz and Khosla Ventures. The reporting frames the event as a substantial opportunity for industry to engage with federal agencies while those agencies wrestle with how to regulate health AI and how to integrate such technologies into payment structures like Medicare.
The source emphasizes that the July 8 demo day and similar conversations were not publicly announced. STAT reviewed the event agenda, but the article indicates the meetings occurred behind closed doors. The reporting does not indicate whether formal minutes, recordings, or other public records of the demos were published by the agencies or made available after the meeting.
The STAT article is based on the reviewed agenda and conversations with several attending companies. The source does not report the detailed content of the demonstrations, verbatim comments by agency officials, any regulatory commitments or follow-up actions, or whether clinicians, patient representatives, or independent researchers were present. It also does not report specific CMS or HHS representatives who attended, nor any formal policy outcomes from the gathering. The article is presented as an exclusive STAT+ story, and the source indicates portions of the reporting are behind a subscription paywall.
According to the source, the meeting illustrates how federal agencies are engaging directly with private developers of clinical artificial intelligence as they consider regulatory frameworks and payment models. The event allowed regulators to observe real-world demonstrations and gave companies a platform to influence thinking about oversight and reimbursement. Beyond the agenda and company summaries, the source does not provide further documentation of agency positions or policy changes resulting from the meeting.
STAT’s reporting documents a July 8, 2026 closed-door demo day at FDA White Oak that brought together FDA, CMS, and multiple AI health companies. The source lists the participating companies and notes conversations with four attendees who summarized their remarks to regulators. Where the article lacks detail — for example, on demonstration content, officials’ remarks, and any formal outcomes — the source explicitly does not report those specifics. The piece was published by Mario Aguilar on Aug. 5, 2026 and is presented as a STAT+ exclusive; additional content referenced by STAT is available only to subscribers, per the article.